首页>
外国专利>
RECOMBINANT MODIFIED VACCINIA ANKARA VIRUS ENCODING A HER-2 ANTIGEN FOR USE IN TREATING CANCER
RECOMBINANT MODIFIED VACCINIA ANKARA VIRUS ENCODING A HER-2 ANTIGEN FOR USE IN TREATING CANCER
展开▼
机译:编码HER-2抗原的重组修饰的痘苗痘病毒用于治疗癌症
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention relates to compositions, kits, and methods for cancer therapy using recombinant MVA viruses encoding a tumor-associated antigen, such as HER-2, particularly in combination with taxanes. The taxanes can be administered prior to, at the same time as, or after the recombinant MVA virus.
展开▼